Frontlight ResearchEarly access
What researchers published on Melanoma
31,906 papers, newest first.
Showing 20 of 677
Trial resultTinostamustine-nivolumab therapy is associated with antigen-specific cellular and humoral immune responses in heavily pre-treated patients with advanced melanoma.Cancer immunology, immunotherapy : CII
In plain wordsRead moreRead the paper on PubMedTrial resultNeoadjuvant pepinemab in combination with nivolumab and/or ipilimumab in resectable metastatic melanoma: a pilot biomarker-driven trial.Nature communications
In plain wordsRead moreRead the paper on PubMedTrial resultMicrobiome-derived TOPOSCORE is associated with response to immune checkpoint inhibitor re-induction after chemotherapy in primary resistant metastatic melanoma.Cancer immunology, immunotherapy : CII
In plain wordsRead moreRead the paper on PubMedTrial resultThe conformation-selective PI3Kδ inhibitor roginolisib in patients with advanced or metastatic cancer, including metastatic uveal melanoma: first-in-human clinical trial.Nature communications
In plain wordsRead moreRead the paper on PubMedRandomised trialPsychosocial mediators for the impact of personal genomic risk information on melanoma prevention and early detection behaviors.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine
In plain wordsRead moreRead the paper on PubMedTrial resultType II RAF Inhibitor Tovorafenib in Recurrent/Refractory Melanoma or Other Solid Tumors With BRAF Fusions or CRAF/RAF1 Fusions or Amplification: Phase II FIRELIGHT-1 Substudy.JCO precision oncology
In plain wordsRead moreRead the paper on PubMedTrial resultPragmatic randomised controlled trial to evaluate the clinical and cost-effectiveness of compression therapy for surgical wounds healing by secondary intention following excision of lower limb keratinocyte cancers in UK skin cancer surgery centres (HEALS2 trial): study protocol.BMJ open
Randomised trialB cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.The Journal of clinical investigation
In plain wordsRead moreRead the paper on PubMedTrial resultA Coordinated Approach to Perioperative Rehabilitation to Enhance Outcomes in Melanoma: Protocol for the CARE-Melanoma Pilot Randomized Controlled Trial.JMIR research protocols
Trial resultImmune-cytokine signature predicts survival in patients with advanced melanoma treated with oncolytic adenovirus TILT-123 and chemotherapy and IL-2-free adoptive TIL therapy.Journal for immunotherapy of cancer
In plain wordsRead moreRead the paper on PubMedTrial resultPhase II Trial of First-line Axitinib plus Nivolumab in Patients with Advanced Mucosal Melanoma.Clinical cancer research : an official journal of the American Association for Cancer Research
In plain wordsRead moreRead the paper on PubMedRandomised trialCOMBI-I: Long-Term Overall Survival With Spartalizumab Plus Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
In plain wordsRead moreRead the paper on PubMedRandomised trialNeoadjuvant Intralesional Daromun (L19IL2/L19TNF) in Resectable Locally Advanced Melanoma: An Update on the Efficacy and Safety Results of the PIVOTAL Phase III Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology
In plain wordsRead moreRead the paper on PubMedRandomised trialCirculating Thymidine Kinase Activity Predicts Survival and Optimal Treatment Sequencing in BRAF-Mutated Metastatic Melanoma in the SECOMBIT Trial.Clinical cancer research : an official journal of the American Association for Cancer Research
In plain wordsRead moreRead the paper on PubMedTrial resultThe Rural Adult and Youth Skin protection study (RAYS): Protocol for a sun protection intervention trial in rural Utah and West Virginia sports programs.Contemporary clinical trials
Randomised trialprimary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma.European journal of cancer (Oxford, England : 1990)
In plain wordsRead moreRead the paper on PubMedTrial resultAn anti-PMEL antibody-drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.Nature medicine
In plain wordsRead moreRead the paper on PubMedTrial resultTopical betulinic acid for treatment of equine melanoma and sarcoid.Frontiers in veterinary science
In plain wordsRead moreRead the paper on PubMedRandomised trialMind the Gap: Impact of New Labels on Public Perceptions and Calculated Risk of Adverse Outcomes after a Melanoma In Situ Diagnosis-A Secondary Analysis of an Online Randomized Experiment.Medical decision making : an international journal of the Society for Medical Decision Making
In plain wordsRead moreRead the paper on PubMedTrial resultEfficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumor.Journal of veterinary internal medicine
In plain wordsRead moreRead the paper on PubMed